AstraZeneca’s SERENA-6 Trial Marks Breakthrough in Breast Cancer Treatment
WILMINGTON, DE — Groundbreaking results from AstraZeneca’s Phase III SERENA-6 trial reveal a significant leap forward…
Eli Lilly’s Zepbound Outperforms Wegovy In New Obesity Trial, But Trump’s Drug Pricing Plan Keeps Retail Traders Wary
Eli Lilly and Company’s obesity medication, Zepbound, resulted in more significant weight reduction compared to Novo…
